Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TNK-tPA as effective as tPA, studies show

Aug. 27, 1997

PRISM-PLUS results on tirofiban released

Aug. 27, 1997

Initial PURSUIT trial results presented in Stockholm

Aug. 25, 1997

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Stanford announces three studies on leg ischemia treatments

Aug. 20, 1997

Glaxo Wellcome discloses a new series of thrombin inhibitors

Aug. 18, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Normiflo launched in U.S.

Aug. 12, 1997

Dietary changes may pose threat to patients on oral anticoagulants

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.